Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Xos, Inc. (XOS) Q3 Earnings Top Estimates
Xos, Inc. (XOS) Q3 Earnings Top Estimates

Xos, Inc. (XOS) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of a loss of $0.73 per share. This compares to a loss of $1.32 per share a year ago. These

Beazer Homes (BZH) Q4 Earnings and Revenues Top Estimates
Beazer Homes (BZH) Q4 Earnings and Revenues Top Estimates

Beazer Homes (BZH) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $1.69 per share a year ago. These figures

Shimmick Corporation (SHIM) Reports Q3 Loss, Tops Revenue Estimates
Shimmick Corporation (SHIM) Reports Q3 Loss, Tops Revenue Estimates

Shimmick Corporation (SHIM) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.72 per share a year ago. These

Profound Medical (PROF) Reports Q3 Loss, Tops Revenue Estimates
Profound Medical (PROF) Reports Q3 Loss, Tops Revenue Estimates

Profound Medical (PROF) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.38 per share a year ago. These figures

Fluent (FLNT) Reports Q3 Loss, Misses Revenue Estimates
Fluent (FLNT) Reports Q3 Loss, Misses Revenue Estimates

Fluent (FLNT) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.22 per share a year ago. These figures are

Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates
Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates

Aytu BioPharma Inc. (AYTU) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.2 per share a year ago. These

TriSalus Life Sciences, Inc. (TLSI) Reports Q3 Loss, Tops Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) Reports Q3 Loss, Tops Revenue Estimates

TriSalus Life Sciences, Inc. (TLSI) came out with a quarterly loss of $0.96 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.4 per share a year ago

TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates
TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates

TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.42 per share a year ago. These figures

Luminar Technologies, Inc. (LAZR) Reports Q3 Loss, Beats Revenue Estimates
Luminar Technologies, Inc. (LAZR) Reports Q3 Loss, Beats Revenue Estimates

Luminar Technologies, Inc. (LAZR) came out with a quarterly loss of $0.94 per share versus the Zacks Consensus Estimate of a loss of $1.05. This compares to a loss of $2.4 per share a year ago

Applied Materials (AMAT) Tops Q4 Earnings and Revenue Estimates
Applied Materials (AMAT) Tops Q4 Earnings and Revenue Estimates

Applied Materials (AMAT) came out with quarterly earnings of $2.17 per share, beating the Zacks Consensus Estimate of $2.11 per share. This compares to earnings of $2.32 per share a year ago. These

Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates

Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.32 per share a year ago. These

Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue Estimates
Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue Estimates

Adherex Technologies Inc. (FENC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.21 per share a year ago

Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates
Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates

Dare Bioscience, Inc. (DARE) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.55 per share a year ago. These

Clipper Realty Inc. (CLPR) Q3 FFO Beat Estimates
Clipper Realty Inc. (CLPR) Q3 FFO Beat Estimates

Clipper Realty Inc. (CLPR) came out with quarterly funds from operations (FFO) of $0.13 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to FFO of $0.18 per share a

Disney’s 2026 Outlook Brightens Under Iger's Magic Touch: https://www.marketbeat.com/logos/articles/med_20251113092950_iger-magic-set-disney-investors-up-for-robust-gain.png
Disney’s 2026 Outlook Brightens Under Iger's Magic Touch

It’s taken time, but Bob Iger’s magic is working on The Walt Disney Company (NYSE: DIS), setting its investors up for robust share price gains in 2026. While the Q4 results were mixed, providing

Top Research Reports for NVIDIA, Micron Technology & Thermo Fisher
Top Research Reports for NVIDIA, Micron Technology & Thermo Fisher

Thursday, November 13, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA

AI Frenzy: Everybody Wants NVIDIA's Magical GPUs
AI Frenzy: Everybody Wants NVIDIA's Magical GPUs

The AI frenzy continues to dominate headlines, with poster child NVIDIA NVDA at the forefront of conversations. The company largely remains the go-to pick concerning AI from a demand standpoint

Forget Netflix—Paramount Skydance’s $3B Plan Is Turning Heads on Wall Street: https://www.marketbeat.com/logos/articles/med_20251112143928_forget-netflixparamount-skydances-3b-plan-is-turni.jpg
Forget Netflix—Paramount Skydance’s $3B Plan Is Turning Heads on Wall Street

In the crowded and competitive streaming landscape, a decisive market reaction can speak volumes. Following its first post-merger earnings report, shares of Paramount Skydance (NASDAQ: PSKY)

Airline Stocks to Watch as the Government Shutdown Ends
Airline Stocks to Watch as the Government Shutdown Ends

Airline stocks have been pleasantly resilient, with many seeing a nice spike as the 43-day and longest government shutdown in American history comes to an end.

This makes it a worthy topic of which

Do Options Traders Know Something About BRLT Stock We Don't?: https://staticx-tuner.zacks.com/images/articles/main/60/1774.jpg
Do Options Traders Know Something About BRLT Stock We Don't?

Investors in Brilliant Earth Group, Inc. BRLT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 21, 2025 $7.5 Call had some of the

Is the Options Market Predicting a Spike in BWIN Stock?
Is the Options Market Predicting a Spike in BWIN Stock?

Investors in The Baldwin Insurance Group, Inc. BWIN need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $22.5 Callhad some of the

3 Hidden Gem AI Stocks to Buy Now
3 Hidden Gem AI Stocks to Buy Now
  • (0:30) - Finding Hidden AI Stocks That You Should Consider For Your Portfolio
  • (9:00) - How To Screen For Zacks #1 Rank Stocks
  • (16:05) - Tracey’s Top Stock Picks For Your Watchlist
  • (41:10) -
Spectrum Brands' Q4 Earnings Beat Estimates, Organic Sales Dip 6.6% Y/Y
Spectrum Brands' Q4 Earnings Beat Estimates, Organic Sales Dip 6.6% Y/Y

Spectrum Brands Holdings Inc. SPB has reported mixed fourth-quarter fiscal 2025 results, wherein the top line missed the Zacks Consensus Estimate while the bottom line beat. Earnings improved year

BDX Unveils Portable PureWick System for On-the-Go Incontinence Care
BDX Unveils Portable PureWick System for On-the-Go Incontinence Care

Becton, Dickinson and Company BDX, popularly known as BD, expanded its PureWick portfolio with a new first-of-its-kind Portable Collection System designed to help wheelchair users manage urinary

Is ARM Stock Still a Smart Bet After Its Record Q2 Results?
Is ARM Stock Still a Smart Bet After Its Record Q2 Results?

Investors were waiting to see how the market would respond to Arm Holdings plc’s ARM impressive second-quarter fiscal 2026 earnings and the reaction has been cautious.

Despite reporting another